◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Kringle Pharma,Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Sep 30, 2025FY 2024Sep 30, 2024FY 2023Sep 30, 2023FY 2022Sep 30, 2022FY 2021Sep 30, 2021
+Revenue 72.2M 80.0M 69.2M 391.8M 289.8M
Revenue Growth % -9.8% 15.6% -82.3% 35.2% --
+Operating Income -909.5M -817.9M -888.8M -426.2M -357.9M
Operating Margin % -1259.4% -1021.9% -1283.4% -108.8% -123.5%
Non Operating Income 1.6M 62.9M 43.4M 104.2M 82.3M
Non Operating Expenses 6.9M -- 7.3M 8.4M 24.1M
Ordinary Income -914.8M -755.0M -852.7M -330.3M -299.7M
Income Before Taxes -914.8M -755.0M -852.7M -330.3M -299.7M
Income Taxes 1.5M 1.5M 1.5M 1.5M 1.5M
+Net Income -916.3M -756.5M -854.2M -331.8M -301.2M
Net Margin % -1268.8% -945.1% -1233.4% -84.7% -103.9%
Eps -133.92 -118.21 -158.46 -68.33 -72.51
Line ItemFY 2025Sep 30, 2025FY 2024Sep 30, 2024FY 2023Sep 30, 2023FY 2022Sep 30, 2022FY 2021Sep 30, 2021
Cash And Deposits 1.6B 2.3B 2.1B 2.8B 2.1B
Current Assets 2.1B 2.8B 2.6B 3.2B 2.6B
Noncurrent Assets 23.9M 1.1M 1.0M 1.0M 1.0M
Total Assets 2.1B 2.8B 2.6B 3.2B 2.6B
Current Liabilities 109.3M 128.2M 209.1M 162.8M 127.2M
Total Liabilities 770.1M 648.9M 597.0M 419.5M 129.5M
Retained Earnings -1.7B -756.5M -1.2B -331.8M -301.2M
Total Equity 1.3B 2.1B 2.0B 2.8B 2.5B
Equity Ratio 0.61 0.76 0.77 0.87 0.95
Book Value Per Share 182.30 306.87 363.45 517.75 578.17
Num Employees 17.00 15.00 13.00 12.00 11.00
Line ItemFY 2025Sep 30, 2025FY 2024Sep 30, 2024FY 2023Sep 30, 2023FY 2022Sep 30, 2022FY 2021Sep 30, 2021
Operating Cash Flow -755.8M -661.2M -689.1M 15.8M -560.9M
Investing Cash Flow -154.0M -121.4M -120.9M -254.4M --
Financing Cash Flow 84.1M 838.2M 69.2M 603.1M 595.9M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...